ATRI's own Rema Raman, PhD, co-Principal Investigator of the Institute on Methods and Protocols for Advancement of Clinical Trials in Alzheimer’s and related dementias (IMPACT-AD), is dedicated to accelerating breakthroughs in Alzheimer’s disease research. That’s why we are excited to share information about the IMPACT-AD 2025 Informational Webinar, a fantastic opportunity for anyone passionate about making a difference in Alzheimer's and related dementias (ADRD) clinical trials.
What is IMPACT-AD?
IMPACT-AD is a prestigious, multidisciplinary clinical trial training program designed to equip researchers with the knowledge and skills needed to lead the next wave of ADRD clinical trials. Funded by the National Institute on Aging and the Alzheimer's Association, this CME-accredited course offers intensive training in the latest methods and protocols for designing, conducting, and analyzing clinical trials for Alzheimer's and related dementias.
Why Attend the Webinar?
This free online webinar on January 14, 2025 (10:00 AM – 11:00 AM PST) is your chance to:
A Commitment to Diversity
IMPACT-AD is committed to fostering a diverse and inclusive research community. They actively seek applicants from a wide range of backgrounds, including:
Register for the free IMPACT-AD Informational Webinar today.